Treace Medical Concepts, Inc. TMCI Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 79.7%-0.1pp | 79.8%-0.1pp | 79.9%-0.2pp | 80.1%-0.1pp | 80.2%-0.1pp | |
| Operating margin | -26.9%-1.4pp | -25.5%-3.3pp | -22.1%+0.3pp | -22.4%+2.4pp | -24.8%+1.8pp | |
| Net margin | -29.4%-1.7pp | -27.7%-4.8pp | -22.9%+0.1pp | -23%+2.1pp | -25.1%+1.5pp | |
| EBITDA margin | -22.5%-2.0pp | -20.5%-2.9pp | -17.5%+0.5pp | -18%+2.6pp | -20.6%+2.0pp | |
| Free cash flow margin | -12.5%+1.3pp | -13.9%-1.8pp | -12%+1.6pp | -13.6%+3.9pp | -17.5%+5.8pp | |
| Returns | ||||||
| Return on equity | -66.9%-7.9pp | -58.9%-7.3pp | -51.6%-4.7pp | -46.9%-1.2pp | -45.7%-1.3pp | |
| Return on assets | -31.3%-2.4pp | -28.9%-4.5pp | -24.5%-1.7pp | -22.7%+0.9pp | -23.6%+0.1pp | |
| Return on invested capital | -37.1%-3.2pp | -33.9%-3.1pp | -30.8%-1.2pp | -29.6%+0.4pp | -30%+0.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×0.0× | 1×0.0× | 1.1×+0.1× | 1×0.0× | 0.9×0.0× | |
| Inventory turnover | 1.1×0.0× | 1.1×+0.1× | 1×0.0× | 1×-0.1× | 1.1×-0.1× | |
| Liquidity | ||||||
| Current ratio | 3.6×-0.7× | 4.3×+0.9× | 3.4×-0.1× | 3.5×-1.0× | 4.5×-0.1× | |
| Quick ratio | 2.5×-0.6× | 3.1×+0.8× | 2.4×-0.2× | 2.5×-0.8× | 3.4×-0.1× | |
| Cash ratio | 0.3×-0.1× | 0.3×+0.2× | 0.2×0.0× | 0.2×-0.2× | 0.4×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×+0.1× | 0.8×0.0× | 0.8×+0.1× | 0.7×+0.1× | 0.7×0.0× | |
| Debt-to-assets | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Interest coverage | -10×+0.2× | -10.2×-1.0× | -9.2×-0.1× | -9.1×+0.9× | -10×+0.6× | |
| Per Share | ||||||
| Book value per share | $1.20-13.4% | $1.38-1.7% | $1.40-9.4% | $1.55-7.8% | $1.68-7.5% | |
| Valuation | ||||||
| Market capitalization | $258.19M-26.6% | $156.11M-63.2% | $423.89M+13.8% | $372.4M-29.1% | $525.37M+13.4% | |
| Enterprise value | $320.25M-22.6% | $217.26M-55.3% | $486.58M+12.0% | $434.44M-25.3% | $581.36M+11.4% | |
| Price / sales | 1.3×-0.4× | 0.7×-1.2× | 1.9×+0.2× | 1.7×-0.7× | 2.5×+0.3× | |
| Price / book | 3.3×-0.3× | 1.8×-3.0× | 4.8×+0.9× | 3.8×-1.2× | 5×+0.9× | |
| EV / sales | 1.5×-0.4× | 1×-1.2× | 2.2×+0.2× | 2×-0.7× | 2.8×+0.3× | |
| Free cash flow yield | -10.1%-1.8pp | -18.9%-12.7pp | -6.2%+1.6pp | -7.8%-0.8pp | -7%+3.5pp | |
| Earnings yield | -23.6%-9.7pp | -37.8%-26.0pp | -11.8%+1.4pp | -13.2%-3.1pp | -10.1%+1.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Treace Medical Concepts, Inc.'s profit margins?
- Treace Medical Concepts, Inc. (TMCI) runs a 79.7% gross margin and a -26.9% operating margin, with a -29.4% net margin.
- Where do Treace Medical Concepts, Inc.'s ratios come from?
- Every ratio is computed from Treace Medical Concepts, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
